Form 4 Oracle: Boston, MA -- Form4Oracle: Insider Trading Report: Vanda Pharmaceuticals Inc. (VNDA)

Aug 12, 2008 (M2 PRESSWIRE via COMTEX) -- VNDA | Quote | Chart | News | PowerRating -- Several insiders at Vanda Pharmaceuticals Inc. (VNDA) have reported buying more than $231.87K today as the stock was trading at less than 50 percent of its 52-week high. Notable purchases include:

- Polymeropoulos Mihael Hristos, Chief Executive Officer: reported buying $182.37K

- Clark William D, Sr. VP, Chief Business Officer: reported buying $49.50K

For a current, real-time summary of VNDA insider activity, visit http://www.form4oracle.com/company?cik=0001347178&ticker=VNDA

About Form4Oracle

Form4Oracle, LLC specializes in distributing insider trading information published by the SEC, making it accessible and actionable for all types of investors. To learn more about how tracking insider trading activity can improve your investment returns, visit http://www.form4oracle.com.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. Its product portfolio includes Fiapta, a compound for the treatment of schizophrenia and bipolar disorder; VEC-162, a compound for the treatment of sleep and mood disorders; and VSF-173, a compound for the treatment of excessive sleepiness. The company was founded in 2002 and is headquartered in Rockville, Maryland.

--------------------------------------------

The companies referenced in this report have not approved the statements made in this report. This report contains statements that imply risks and uncertainties. This material is for informational reporting purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Form4Oracle is not a licensed broker, broker dealer, market maker, investment banker, investment adviser, analyst or underwriter and is not compensated in this regard.

Please consult your broker to understand investing benefits and risks and prior to purchasing any securities mentioned herein.

CONTACT: Kimberly Sutton, Form4Oracle Tel: +1 312 315 5077 e-mail: kimberly@form4oracle.com WWW: http://www.form4oracle.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index